Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Conditions

• Diffuse Cutaneous Systemic Sclerosis

Interventions

• DRUG: Brentuximab vedotin

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

• [object Object]
• [object Object]